Charles Schwab’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Buy |
|
|||||
|
2025
Q1 | $998K | Buy |
|
|||||
|
2024
Q4 | $767K | Buy |
|
|||||
|
2024
Q3 | $512K | Hold |
|
|||||
|
2024
Q2 | $383K | Buy |
|
|||||
|
2024
Q1 | $85.8K | Hold |
|
|||||
|
2023
Q4 | $35.3K | Hold |
|
|||||
|
2023
Q3 | $36K | Hold |
|
|||||
|
2023
Q2 | $38.7K | Hold |
|
|||||
|
2023
Q1 | $37.7K | Hold |
|
|||||
|
2022
Q4 | $41.4K | Hold |
|
|||||
|
2022
Q3 | $31K | Hold |
|
|||||
|
2022
Q2 | $42K | Sell |
|
|||||
|
2022
Q1 | $314K | Hold |
|
|||||
|
2021
Q4 | $478K | Buy |
|
|||||
|
2021
Q3 | $771K | Buy |
|
|||||
|
2021
Q2 | $1.16M | Buy |
|
|||||
|
2021
Q1 | $995K | Buy |
|
|||||
|
2020
Q4 | $486K | Buy |
|
|||||
|
2020
Q3 | $386K | Sell |
|
|||||
|
2020
Q2 | $462K | Buy |
|
|||||
|
2020
Q1 | $320K | Sell |
|
|||||
|
2019
Q4 | $442K | Buy |
|
|||||
|
2019
Q3 | $383K | Buy |
|
|||||
|
2019
Q2 | $425K | Buy |
|
|||||
|
2019
Q1 | $355K | Buy |
|
|||||
|
2018
Q4 | $247K | Hold |
|
|||||
|
2018
Q3 | $309K | Hold |
|
|||||
|
2018
Q2 | $267K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $121K | Hold |
|
|||||
|
2016
Q4 | $149K | Hold |
|
|||||
|
2016
Q3 | $134K | Hold |
|
|||||
|
2016
Q2 | $186K | Buy |
|